September 2011

Novartis Obtains Defense Verdict in Jury Trial Against Bisphosphonate Claims

United States - Kentucky

Our firm's trial team obtained a defense verdict for firm client Novartis in a jury trial in federal court in Bowling Green, Kentucky. Novartis manufactures and sells Zometa, a drug indicated to strengthen bone in cancer patients whose disease has metastasized to bone. The plaintiff, a woman suffering from metastatic breast cancer, alleged she developed a condition called osteonecrosis of the jaw (ONJ) as a result of consuming Zometa.

This was one of hundreds of similar cases against Novartis ongoing across the country. Our firm was retained to try this case after the company's national counsel had worked it up through discovery and most pre-trial motions. After a three-week trial, the jury returned a complete defense verdict. Mahaney v. Novartis Pharmaceuticals Corp., United States District Court, W.D. Kentucky, Case No. 1:06-CV-00035-R.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.